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Abstract  Continuous  adjustment  of  Propofol  in  manual  delivery  of  anesthesia  for  conduct-
ing a  surgical  procedure  overburdens  the  workload  of  an  anesthetist  who  is  working  in  a
multi-tasking  scenario.  Going  beyond  manual  administration  and  Target  Controlled  Infusion,
closed-loop  control  of  Propofol  infusion  has  the  potential  to  offer  several  beneﬁts  in  terms  of
handling perturbations  and  reducing  the  effect  of  inter-patient  variability.  This  paper  proposes
a closed-loop  automated  drug  administration  approach  to  control  Depth  Of  Hypnosis  in  anes-
thesia. In  contrast  with  most  of  the  existing  research  on  anesthesia  control  which  makes  use  of
linear control  strategies  or  their  improved  variants,  the  novelty  of  the  present  research  lies  in
applying robust  control  strategy  i.e.  Sliding  Mode  Control  to  accurately  control  drug  infusion.
Based on  the  derived  patient’s  model,  the  designed  controller  uses  measurements  from  EEG
to regulate  DOH  on  Bispectral  Index  by  controlling  infusion  rate  of  Propofol.  The  performance
of the  controller  is  investigated  and  characterized  with  real  dataset  of  8  patients  undergo-
ing surgery.  Results  of  this  in  silico  study  indicate  that  for  all  the  patients,  with  0%  overshoot
observed,  the  steady  state  error  lies  in  between  ±5.  Clinically,  this  implies  that  in  all  the  cases,
without  any  overdose,  the  controller  maintains  the  desired  DOH  level  for  smooth  conduction  of
surgical procedures.
©  2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
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Controle  da  hipnose  na  administrac¸ão de  propofol  com  base  na  estratégia  de  controle
não  linear
Resumo  O  ajuste  contínuo  de  propofol  na  administrac¸ão  manual  de  anestesia  para  a  realizac¸ão
de um  procedimento  cirúrgico  onera  a  carga  de  trabalho  de  anestesiologistas  que  trabalham  em
ambiente multitarefa.  Indo  além  da  administrac¸ão  manual  e  da  infusão  alvo-controlada  (IAC),  o
controle de  circuito  fechado  da  infusão  de  propofol  tem  o  potencial  de  oferecer  vários  benefícios
em termos  de  manejo  das  perturbac¸ões  e  reduzir  o  efeito  da  variabilidade  interpaciente.  Este
artigo propõe  uma  abordagem  para  a  administrac¸ão  automatizada  de  drogas  em  circuito  fechado
para controlar  a  profundidade  da  hipnose  (PDH)  em  anestesia.  Em  contraste  com  a  maioria  das
pesquisas  existentes  sobre  o  controle  da  anestesia  que  usam  estratégias  de  controle  linear  ou
de suas  variantes  melhoradas,  a  novidade  da  presente  pesquisa  reside  na  aplicac¸ão  de  uma
estratégia  de  controle  robusto;  isto  é,  o  Controle  por  Modos  Deslizantes  (CMD)  para  controlar
com precisão  a  infusão  da  droga.  Com  base  no  modelo  derivado  do  paciente,  o  controlador
projetado usa  as  medic¸ões  do  EEG  para  regular  a  PDH  no  Bispectral  Index  (BIS),  controlando  a
taxa de  infusão  de  propofol.  O  desempenho  do  controlador  é  investigado  e  caracterizado  com
um conjunto  de  dados  reais  de  oito  pacientes  submetidos  à  cirurgia.  Os  resultados  deste  estudo
in silico  indicam  que,  para  todos  os  pacientes,  com  0%  de  excesso  observado,  o  erro  de  estado
estacionário  ﬁca  entre  ±  5.  Clinicamente,  isso  implica  que  em  todos  os  casos,  sem  qualquer
sobredosagem,  o  controlador  mantém  o  nível  desejado  de  PDH  para  a  conduc¸ão  tranquila  dos
procedimentos  cirúrgicos.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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hanks  to  technological  advancements,  the  beneﬁts  offered
y  modern  medicine  have  totally  transformed  the  concept
f  clinical  surgery.  Nowadays,  surgical  procedures  can  be
erformed  with  much  ease  and  comfort.  This  incredible
ilestone  has  been  achieved  only  through  the  research
utcomes  in  modern  anesthesia.  Prior  to  the  discovery  of
nesthesia,  surgery  has  to  be  conducted  extremely  fast.
istorically,  trivial  techniques  like  application  of  cold,
ompression  of  nerve  or  reduction  in  cerebral  perfusion
ere  employed  to  keep  patient  unconscious.1 Undoubtedly,
nvention  of  inhalation  gases  in  1840  by  Hickman  was  a
ivotal  step  toward  discovery  of  anesthesia  to  ﬁnally  per-
it  conduction  of  invasive  surgeries.  The  ﬁrst  procedure  of
nesthesia,  based  on  diethyl  ether,  was  performed  in  1842
y  C.W.  Long.  This  new  revolutionary  concept  was  later  on
ermed  as  anesthesia  meaning  lack  of  esthesia  i.e.  sense.
Anesthesia  is  intensively  used  particularly  in  medical
omain  in  many  applications  including  surgical  operation
ith  incision,  dental  surgery  and  intensive  care.2 The  pri-
ary  objective  of  anesthesia  is  to  offer  painless  feelings  to
 patient  under  operation  by  driving  him/her  into  uncon-
cious  state  without  memory.  The  overall  functional  scenario
f  anesthesia  can  be  categorized  into  three  temporal  phase
n  sequence:  induction,  maintenance  and  emergence.  Dur-
ng  the  ﬁrst  phase,  the  objective  is  to  bring  a  patient  to
 reference  Depth  of  Hypnosis  (DOH).  It  is  then  necessaryPlease  cite  this  article  in  press  as:  Ilyas  M,  et  al.  Regulation  o
non-linear  control  strategy.  Rev  Bras  Anestesiol.  2016.  http://
o  administer  the  anesthetic  drug  in  order  to  maintain  an
dequate  DOH.  For  induction  and  maintenance  of  anesthe-
ia,  commonly  used  intravenously  administered  anesthetic
rug  is  Propofol.3 During  emergence  phase  in  post-surgery
p
b
sctivities,  vaporizer  and  other  infusion  devices  are  turned
ff  so  as  to  enable  patients  to  awake  fast.
During  general  anesthesia,  Propofol  is  usually  used
ogether  with  fast  acting  opioids  e.g.  remifentanil  to  have
 synergistic  effect.4 Under-dosing  of  anesthetic  drugs  may
ead  to  insufﬁcient  analgesia  or  awareness.  On  the  other
and,  it  is  dangerous  for  patients  to  have  excessive  amount
f  drug.  Thus  careful  management  of  the  intravenous  drug
elivery  is  the  key  factor  behind  successful  anesthesia
ractice.  It  is  desirous  to  access  the  depth  of  anesthesia
ogether  with  automatic  and  interactive  drug  administration
ith  little  human  intervention  so  as  to  adjust  drug  dosage
ccordingly  for  balancing  the  anesthetic  state,  autonomic
unction  and  response  to  noxious  stimuli.
The  procedures  to  administer  intravenous  drug  deliv-
ry  have  been  evolved  from  simple  manual  delivery  and
omputer-assisted  automated  Target  Controlled  Infusion
TCI)  to  more  sophisticated  Closed-Loop  ANesthesia  (CLAN).
raditionally,  hypnotic  drug  delivery  rates  in  intravenous
nesthesia  are  manually  controlled  by  an  anesthetist.  Doses
re  principally  decided  based  on  patient  demographics,
ualitatively  measured  signs  (e.g.  presence  of  certain
eﬂexes,  movement)  and  quantitatively  measured  signals
e.g.  oxygen  saturation,  blood  pressure,  heart  rate).  The
osage  scheme  is  then  tuned  by  hit  and  trial  to  opti-
ize  anesthesia  and  to  evade  toxicity.  TCI,  also  known  as
omputer  Assisted  Continuous  Infusion  (CACI),5 relies  on
opulation-based  pharmacokinetic  (PK)  and  pharmacody-
amic  (PD)  models6 for  calculating  an  adequate  infusionf  hypnosis  in  Propofol  anesthesia  administration  based  on
dx.doi.org/10.1016/j.bjane.2015.08.011
roﬁle  to  achieve  the  reference  drug  concentration  set
y  the  anesthesiologist.  Given  the  past  and  present  infu-
ion  rates,  these  models  can  predict  the  time  evolution
ARTICLE IN+ModelBJANE-728; No. of Pages 9
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iFigure  1  BIS  scaling  band  to  indicate  DOH  level.
of  plasma  concentration.  This  prediction  is  then  used  to
track  the  reference  concentration  thus  devising  an  open  loop
control  paradigm.  Instead  of  adjusting  the  infusion  rate,
the  anesthetist  manipulates  the  reference  concentration,
both  reactively  and  proactively,  using  commercially  avail-
able  infusion  pumps.  TCI  systems  suffer  from  drawbacks  of
sensitivity  to  model  non-linearities  and  disturbances  since
there  is  no  feedback  of  measurement  on  drug  effect.  These
drawbacks  can  be  addressed  by  closing  the  control  loop
through  DOH  measurement,  which  is  given  by  EEG-based
monitors  e.g.  Bispectral  Index  (BIS).7 The  value  of  BIS  is
mapped  to  the  DOH  level  of  a  patient  based  on  the  scal-
ing  band  shown  in  Fig.  1.  The  value  of  100--90  corresponds
to  a  fully  awake  state  while  level  of  90--60  and  60--40
indicate  light  and  moderate  hypnosis  levels  respectively.8
The  moderate  level  represents  the  surgical  procedure  band
in  which  general  surgery  is  performed  by  clinical  profes-
sionals.  Level  beyond  deep  hypnotic  state  (40--20)  is  quite
dangerous.9
In  a  CLAN  system,  drug  effect  is  measured  in  real  time
and  is  compared  with  the  reference  DOH  to  obtain  an  error
signal.  Based  on  which,  the  system  subsequently  adjusts  a
drug  infusion  rate.  A  CLAN  system  offers  several  beneﬁts  in
comparison  with  a  TCI  system  including  automatic  handling
of  perturbations,  precise  control  of  drug  infusion  rate,  min-
imizing  the  effect  of  patient  variability  and  reducing  the
need  of  anesthetist  intervention.
Trend  to  realize  a  CLAN  system  has  been  based  on  trivial
or  linear  control  approaches.10 Dong2 proposed  a  CLAN  sys-
tem  for  total  intravenous  anesthesia  based  on  Proportional,
Integral,  Derivative  (PID)  controller.  With  BIS  as  sensory
feedback  and  Digital  Signal  Processing  (DSP)  based  super-
visory  system,  the  realized  system  was  tested  on  21  healthy
volunteers  and  15  patients  undergoing  surgery.  Except  for
the  2  patients,  satisfactory  clinical  results  were  obtained.
Another  study11 based  on  PID  control  investigated  the  con-
trol  performance  with  10  patients  undergoing  elective  hip  or
knee  surgery.  The  median  absolute  performance  error  was
found  to  be  8%.  The  control  strategy  was  able  to  provide
adequate  anesthesia  in  9  patients  with  oscillatory  response
recorded  in  BIS  values  for  3  patients.  Other  prominent
studies  reporting  PID  control  of  anesthesia  include.12,13 Com-
paring  conventional  PID  with  Linear  Model  Predictive  Control
(LMPC),  it  is  reported  in  Ref.  14  that  the  later  approach  out-
performs  in  terms  of  robustness  to  intra  and  inter-patient
dynamics  and  handling  disturbances,  constraints  and  mea-
surement  noise.  Recent  studies15--18 aim  to  improve  linearPlease  cite  this  article  in  press  as:  Ilyas  M,  et  al.  Regulation  o
non-linear  control  strategy.  Rev  Bras  Anestesiol.  2016.  http://d
approaches  by  properly  tuning  the  controllers  to  achieve
sufﬁcient  robustness  margins  for  identiﬁable  uncertainties.
However,  for  control  laws  based  on  the  linear  approaches,
the  model  of  a  patient,  exhibiting  a  non-linear  behavior,  is
t
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thesia  3
inearized.  Such  approximation  achieves  good  control  per-
ormance  only  if  the  difference  between  the  predicted
nd  actual  closed-loop  systems  is  small  for  the  designed
ontroller.19 The  traditional  PID  controller  cannot  handle
isturbances  like  blood  pressure  changes,  neural  muscu-
ar  blockade  and  heart  rate  variability10 and  may  result
n  oscillatory  behavior  during  clinical  trials.  Also  for  wide
cceptance  of  a  CLAN  system  by  clinical  professionals  and
egulatory  bodies,  guarantees  of  robust  stability  and  per-
ormance  are  must.  Employing  a  non-linear  and  robust
ontrol  strategy  is  therefore  need  of  the  hour  in  clinical
nesthesia.
This  research  is  aimed  at  unleashing  the  potential  of
 sophisticated  control  strategy  i.e.  Sliding  Mode  Control
SMC)  to  manage  Propofol  anesthesia  infusion  rate.  The
aper  is  organized  as  follows:  Section  II  derives  patient
odel.  Section  III  explains  the  design  details  of  SMC
hile  Section  IV  presents  results  based  on  clinical  param-
ters  of  actual  patients.  Finally  Section  V  comments  on
onclusion.
atient model
he  dynamics  of  the  hypnotic  drug  is  categorized  in  its  phar-
acokinetics  (PK)  and  pharmacodynamics  (PD)  parameters.
he  PK  parameter  is  used  to  govern  the  behavior  of  the
nfused  drug  in  the  body  over  time  including  its  distribu-
ion,  metabolism,  absorption  and  clearance20 while  the  PD
arameter  represents  the  drug  concentration  in  the  blood
nd  the  corresponding  impact  caused  at  the  effect  site.21
On  the  basis  of  blood  ﬂow  in  different  organs,  medical
iterature  divides  human  body  into  various  compartments.22
ompartmental  model  represents  a  basic  kinetic  approach
o  describe  drug  absorption,  distribution  and  elimination.23
elating  plasma  drug  levels  to  PD  parameters,  this  model
s  intensively  used  in  various  biomedical  and  biotechnical
pplications  because  of  their  inherent  ﬂexibility  and  simplic-
ty.  The  integrated  PKPD  structure  follows  compartmental
odeling.  In  the  present  study,  a  three  compartment  PK
odel  with  an  additional  effect  compartment  has  been
dopted  owing  to  its  sufﬁcient  precision  and  computational
fﬁciency.24 Centred  on  a  primary  compartment  (intravascu-
ar  blood)  with  volume  V1, a  rapid  peripheral  compartment
muscle)  and  a  slow  peripheral  compartment  (fat),  with  vol-
mes  V2 and  V3 respectively,  are  connected  to  the  primary
ompartment.  Thus  distribution  and  elimination  of  the  drug
etween  primary  and  peripheral  compartments  take  place
ith  weighted  rate  constants  k12,  k21,  k13,  k31 as  depicted
n  Fig.  2. At  any  time,  the  change  in  concentration  of  drug
n  primary  compartment  is  related  to  the  drug  moved  to
nd  from  the  rapid  and  slow  peripheral  compartments.  The
nduction  and  clearance  of  the  drug  takes  place  through
he  primary  compartment.  The  drug  eliminates  from  this
ompartment  in  an  exponential  fashion.17 At  the  effect  side
brain),  the  concentration  of  the  drug  is  measured  through
he  cortical  activity  in  the  brain  measured  through  the  mod-
ﬁed  form  of  EEG  signal.25 The  extracted  information  canf  hypnosis  in  Propofol  anesthesia  administration  based  on
x.doi.org/10.1016/j.bjane.2015.08.011
hen  be  mapped  to  Depth  Of  Hypnosis  (DOH)  so  as  to  analyze
atient’s  suitability  for  surgical  procedures.
Table  1  shows  the  nomenclature  for  derivation  of  patient
odel.
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Table  1  Nomenclature.
Symbol  Unit  Name
u(t)  mg  seg−1 Infusion  rate
k10 seg−1 Elimination  rate  constant
x1 mg  Amount  of  drug  in  primary
compartment
x2 mg  Amount  of  drug  in  rapid
peripheral  compartment
x3 mg  Amount  of  drug  in  slow
peripheral  compartment
xe mg  Flow  of  hypnotic  agent  in
effect  site
k1e s−1 Rate  constant  at  effect  site
ke0 seg−1 Elimination  rate  constant  at
effect  site
Ce mg  L−1 Effect  site  concentration
E0 --  Awake  stage  (100--90)
Emax --  Maximum  effect  achieved
by drug  infusion
C50 mg  L−1 Drug  concentration  at  half
of the  maximum  effect
v
a
D
o
H
C
B
w
C
C
T
cFigure  2  Block  diagram  of  PK  and  PD  models.
To  derive  the  PK  model,  state  equations  corresponding  to
he  three  compartments  can  be  written  as  (1)--(3)
˙1(t)  =  −k10x1(t)  −  k12x1(t)  −  k13x1(t)  +  k21x2(t)
+  k31x3(t)  +  u(t)  (1)
˙2(t)  =  −k12x1(t)  −  k21x2(t)  (2)
˙3(t)  =  −k13x1(t)  −  k31x3(t)  (3)
Laplace  transform  of  (1)--(3)  yields  (4)--(6)
X1(s)  =  −(k10 +  K12 +  K13)X1(s)  +  k21X2(s)  +  k31X13(s)  +  (t)
(4)
X2(s)  =  k12X1(s)  −  k21X2(s)  (5)
X23(s)  =  k13X1(s)  −  k31X3(s)  (6)
Solving  (4)--(6),  the  input--output  relationship  can  be
ritten  as  (7)
p(s)  = X1(s)
U(s)
= (s
2 +  s(k21 +  k3
(s3 +  s2(k10 +  k12 +  k21 +  k13 +  k31)  +  s(k10k2
here  Dp(s)  is  the  rate  of  drug  absorption/metabolism
ithin  the  body  deﬁned  as  disposition  rate.  Rewriting  (7),
he  general  form  of  PK  model  is  obtained  as
p(s)  = X1(s)
U(s)
= b2s
2 +  b1s  +  b0
a3s3 +  a2s2 +  a1s  +  a0 (8)
here  b2 =  1,  b1 =  21 +  31,  b0 =  2131,  a3 =  1,
2 =  (10 +  12 +  13 +  31),  a1 =  1021 +  1031 +  1231 +
1321 +  3121,  a0 =  102131
The  PD  model  indicating  level  of  consciousness  relates
oncentration  of  the  drug  in  plasma  to  the  effect  site
oncentration  and  can  be  derived  based  on  the  state  Eq.
9)
˙e(t)  =  k1ex1(t)  −  ke0xe(t)  (9)Please  cite  this  article  in  press  as:  Ilyas  M,  et  al.  Regulation  o
non-linear  control  strategy.  Rev  Bras  Anestesiol.  2016.  http://
Applying  Laplace  transform  on  (9)
Xe(s)  =  k1eX1(s)  −  ke0Xe(s)  (10)
t
f
B
b k21k31)
10k31 +  k13k21 +  k31k21)  +  (k10k21k31)) (7)
 --  Sigmoid  curve  slope
parameter
Considering  k1e and  ke0 are  equal  because  of  its  negligible
olume  of  the  effect  site  compartment,  the  disposition  rate
t  the  effect  side  is  given  by  (11)
e(s)  = Xe(s)
X1(s)
= ke0
(s  +  ke0) (11)
Based  on  the  cascaded  nature  of  PK  and  PD  models,  the
verall  patient  model  can  ﬁnally  be  written  as
p(s)  = ke0(s  +  Xe0) ∗
b2s
2 +  b1s  +  b0
a3s3 +  a2s2 +  a1s  +  a0 (12)
BIS  is  related  with  anesthetic  effect  site  concentration
e(t)
y through  nonlinear  sigmoid  model  i.e.
IS(t)  =  E0 −  Emax ∗ Ce(t)

Ce(t)
 +  C50
(13)
here  Ce(t)  can  be  computed  by  integrating  (14)
˙
e(t)  =  −0.1068x1 +  0.456Ce (14)
ontrol design
he  overall  closed-loop  system  in  the  present  study  mainly
onsists  of  SMC  and  cascaded  PK-PD  model.  The  output  off  hypnosis  in  Propofol  anesthesia  administration  based  on
dx.doi.org/10.1016/j.bjane.2015.08.011
his  model  is  fed  to  the  sigmoid  function  also  known  as  Hill
unction,  which  maps  the  output  on  BIS  scale.  The  value  of
IS  is  used  as  a  feedback  to  the  controller.  Fig.  3  presents  the
lock  diagram  of  the  overall  feedback  control  system  used
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to  achieve  the  desired  DOH  during  surgical  procedures.  The
overall  objective  in  the  control  design  is  to  minimize  steady
state  error  so  as  to  maintain  DOH  level  within  acceptable
range  for  surgery.
The  control  law  is  based  on  SMC,  which  is  one  of  the
most  effective  robust  control  techniques  for  highly  nonlin-
ear  systems  operating  in  uncertain  environments  subjected
to  disturbances.  SMC  involves  deﬁning  a  sliding  surface  typ-
ically  a  linear  hyper-surface.  The  fundamental  concept26
behind  SMC  is  to  drive  the  system  dynamics  from  any  initial
state  to  the  sliding  surface  (i.e.  reaching  phase).  The  sys-
tem  is  then  maintained  on  this  surface  for  all  future  values
of  time  (sliding  phase).  The  major  beneﬁt  offered  by  SMC  is
its  low  sensitivity  to  plant  disturbances  and  uncertainties.27
To  design  SMC,  considering  the  sliding  surface  given  by
(15)
  =  a1x1 +  a2x2 +  a3x3 +  a4xe (15)
or
˙  =  a1x˙1 +  a2x˙2 +  a3x˙3 +  a4x˙e (16)
where  a1,  a2,  a3,  a4 are  tuning  parameters  of  the  controller.
With  a1 =  1,  values  of  other  parameters  are  chosen  in  a
way  that  0  becomes  Hurwitz  monic  polynomial.  This  condi-
tion  ensures  reduction  in  order  of  the  system  which  can
be  represented  with  n  −  1  states.  Such  a  system  demon-
strates  insensitivity  to  matched  uncertainties.  Substituting
the  state  equations,  (16)  can  be  re-written  as,
˙  =  a1[(−k10 −  k12 −  k13)x1(t)  +  k21x2(t)  +  k31x3(t)  +  u(t)]
+  a2[k12x1(t)  −  k21x2(t)]  +  a3[k13x1(t)  −  k31x3(t)]
+  a4[k1ex1(t)  −  ke0xe(t)]  (17)Please  cite  this  article  in  press  as:  Ilyas  M,  et  al.  Regulation  o
non-linear  control  strategy.  Rev  Bras  Anestesiol.  2016.  http://d
The  overall  control  law  (u)  consists  of  equivalent  control
(ueq)  and  discontinuous  control  (udisc)  i.e.
u  =  ueq +  udisc (18)
A
A
Table  2  Clinical  dataset  showing  patients’  attributes.
Patient  Age  years  Height  (H),  cm  Weight  (W),  kg  
1  40  163  54  
2 36  163  50  
3 34  172  58  
4 28  164  60  
5 37  187  75  
6 42  179  78  
7 38  174  80  
8 43  163  59  erall  closed-loop  system.
The  equivalent  control  forces  the  system  dynamics  to
ove  to  the  sliding  surface  and  depends  on  the  states  of
he  system  and  state  parameters.  It  makes  the  derivative
f  sliding  manifold  equal  to  zero  and  can  be  computed  by
utting    =  0 along  the  system  dynamics  (17). Thus,
eq =  −[(−k10 −  k12 −  k13)x1(t)  +  k21x2(t)  +  k31x3(t)]
−  a2[k12x1(t)  −  k21x2(t)]  −  a3[k13x1(t)  −  k31x3(t)]
−  a4[k1e1(t)  −  ke0xe(t)]  (19)
Presence  of  disturbances  or  uncertainties  may  lead
 /=  0.  Discontinuous  control  handles  such  disturbances  and
epends  on  gain  and  signum  function,  which  exhibits  switch-
ng  behavior.  Thus,
disc =  −k  sign()  (20)
here  k  ∈  Rn×n is  the  discontinuity  gain  matrix.  Mathemat-
cally,
ign()  =
[
1  for    >  0
−1  for    <  0
]
(21)
To  investigate  and  characterize  the  performance  of  the
esigned  controller,  clinical  data  including  characteristic
ariables  of  eight  patients  is  presented  in  Table  2.8
Based  on  the  patient’s  attributes,  clinical  parameters
omputed  using  Schnider  three  compartmental  model  for
ropofol  are  given  below:
1 =  4.27[l]f  hypnosis  in  Propofol  anesthesia  administration  based  on
x.doi.org/10.1016/j.bjane.2015.08.011
V2 =  18.9  −  0.391(Age  −  53)[l]
V3 =  238[l]
Gender  C50 E0 Emax 
F  6.33  98.80  94.10  2.24
F  6.76  98.60  86.00  4.29
F  4.95  96.20  90.80  1.84
M  4.96  94.70  85.30  2.46
M  8.02  92.00  104.00  2.10
M  4.82  91.80  77.90  1.85
F  6.56  95.50  76.40  4.12
F  12.10  90.20  147.00  2.42
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l1 =  1.89  +  0.0456(W  −  77)  −  0.0681(LBM  −  59)
+  0.0264(H  −  177)
l2 =  1.29  −  0.24(Age  −  53)
l3 =  0.836
here  Lean  Body  Mass  (LBM)  is  a  function  of  patient’s  gender,
eight  and  weight.  For  male  and  female,  it  is  respectivelyPlease  cite  this  article  in  press  as:  Ilyas  M,  et  al.  Regulation  o
non-linear  control  strategy.  Rev  Bras  Anestesiol.  2016.  http://
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2
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r2
The  rate  constants  k10, k12, k13, k21, k31 depend  on  weight,
eight,  age,  gender  of  the  patient  and  are  given  as:
10 = Cl1
V1
12 = Cl2
V1f  hypnosis  in  Propofol  anesthesia  administration  based  on
dx.doi.org/10.1016/j.bjane.2015.08.011
13 = Cl3
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Figure  6  Plasma  drug  concentration  in  (a)  patient  4,  (b)  patient  8,  (c)  patient  2,  and  (d)  patient  7.
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Figure  7  Simulation  results  for  BIS  value  for  various  patients  showing  that  there  is  no  overdose.
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esults and discussion
he  trivial  scheme  of  anesthetic  agent  administration  simply
onsists  of  a  controller-less  paradigm.  With  such  a  scheme,
ig.  4A  presents  plasma  drug  concentration  in  various  com-
artments  while  Fig.  4B  shows  the  output  proﬁle  in  the  form
f  BIS  signal.  BIS  values  are  still  far  away  from  the  desired
OH  level  which  is  required  for  the  general  surgery.  It  is
bserved  from  these  results  that  manipulating  anesthesia
ithout  a  dedicated  controller  in  the  loop  can  be  quite  risky
nd  may  not  be  suitable  in  many  operational  scenarios.  Using
his  scheme,  the  accuracy  and  precision  of  the  drug  deliv-
ry  to  a  patient  during  surgery  is  totally  dependent  on  the
nesthesiologist  experience.  The  critical  response  of  this
ontroller  becomes  more  problematic  and  crucial  especially
n  case  of  children  and  cardiac  patients.
Employing  a  robust  controller  in  a  closed-loop  fashion
ompletely  changes  the  response.  Fig.  5A  presents  the  con-
rolled  drug  infusion  level  using  SMC  technique  for  patient  6.
lasma  drug  concentration  in  the  compartments  of  the  PKPD
tructure  is  illustrated  in  Fig.  5B,  where  the  rate  of  change
f  drug  concentration  with  respect  to  time  in  all  the  four
ompartments  of  the  body  after  the  drug  infusion  is  shown.
nitially  the  drug  concentration  is  maximum  in  the  primary
ompartment.  But  as  the  drug  moves  between  primary  and
eripheral  compartments,  its  level  decays  exponentially
n  the  primary  compartment  and  rises  in  the  peripheral
ompartments.  This  ﬂow  of  drug  in  the  compartments  is  rep-
esented  through  the  use  of  rate  constants.  The  output  of  BIS
ndicator  is  plotted  in  Fig.  5C.  It  clearly  shows  that  the  pres-Please  cite  this  article  in  press  as:  Ilyas  M,  et  al.  Regulation  o
non-linear  control  strategy.  Rev  Bras  Anestesiol.  2016.  http://
nce  of  the  controller  with  a  closed-loop  feedback  system
ramatically  improves  performance  of  anesthesia  process.
he  output  converges  to  the  required  level  of  BIS  for  surgery
ithin  seconds.  The  controller  then  maintains  this  DOH  level
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Figure  9  Propofol  infusion  rigure  8  Steady  state  error  showing  that  DOH  is  under  desired
ange.
o  as  to  assist  anesthesiologist  in  ensuring  safer  region  of
peration.
Plasma  drug  concentration  in  various  compartments  is  a
unction  of  factors  including  patients’  age.  Lesser  the  age
f  a  patient,  faster  is  the  metabolism/elimination  of  the
rug.  As  an  example,  compare  the  drug  concentration  of
atients  4  and  8  illustrated  in  Fig.  6A  and  B  respectively.  It  is
vident  that  patient  4  being  comparatively  younger  demon-
trates  fast  metabolism  of  the  drug  occurring  in  primary
ompartment  than  patient  8.  Comparison  of  young  and  old
atients  discloses  that  the  concentration  in  rapid  peripheral
ompartment  increases  substantially  due  to  the  fast  ﬂow
f  Propofol  from  primary  compartment.  The  same  effect  is
eﬂected  in  slow  peripheral  compartment  and  the  effect  site
ompartment.
In  contrast  to  age,  the  weight  of  a  patient  does  not  sig-
iﬁcantly  affect  the  plasma  drug  concentration  proﬁle.  To
nvestigate  this  effect,  the  concentration  in  patients’  2  and
 (weight  =  30  kg)  has  been  compared  (Fig.  6C  and  D).  It  can
e  seen  that  the  concentration  of  Propofol  in  the  primary
ompartment  of  patient  2  decays  at  a  relatively  same  rate
s  that  of  patient  7.  The  minor  difference  in  the  responses
s  due  to  difference  in  ages  of  the  patients.  Same  fashion  is
bserved  regarding  ﬂow  of  drug  to  other  compartments.
The  designed  controller  with  the  derived  patient’s  modelf  hypnosis  in  Propofol  anesthesia  administration  based  on
dx.doi.org/10.1016/j.bjane.2015.08.011
s  then  simulated  as  per  the  dataset  (Table  2).  Simula-
ion  results  shown  in  Fig.  7  present  the  hypnosis  level  of
 patients  after  the  infusion  of  drug  for  surgery.  These
esponses  indicate  both  the  induction  and  maintenance
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phases  of  anesthesia.  Initially,  during  induction  phase,
patient  is  in  awake  state  (DOH  level  near  100)  and  then  it
enters  into  moderate  hypnotic  state  (DOH  level  of  40--60).
This  level  is  maintained  for  safe  execution  of  surgical  pro-
cedures.  In  this  study,  all  the  patients  achieved  the  ideal
hypnosis  level.  However,  for  the  sake  of  quantiﬁcation,  Fig.  8
shows  steady  state  error  considering  DOH  level  of  50  as
reference.  The  error  bounded  in  between  ±5  is  still  within
acceptable  range  for  surgical  operations.
The  designed  SMC  provides  different  rates  of  Propofol
infusion  corresponding  to  different  patients  (Fig.  9)  due  to
difference  in  patients’  parameters  like  age,  weight,  height,
gender  and  LBM  to  maintain  the  desired  level  of  DOH.  The
controller  initially  permits  injection  of  large  amount  of  drug
to  bring  the  patient  in  unconsciousness  state  in  induction
phase  of  anesthesia.  Once  the  desired  hypnosis  level  is
achieved,  then  the  controller  strictly  maintains  the  speciﬁc
infusion  rate  throughout  the  maintenance  phase  of  anesthe-
sia  for  each  patient.
Conclusions
This  paper  proposes  SMC-based  law  for  adequate  and  safe
delivery  of  Propofol  anesthesia  for  achieving  desired  hypno-
sis  levels.  Simulation  results  based  on  the  dataset  comprising
of  8  real  patients  with  different  clinical  parameters  clearly
witness  efﬁcacy  of  the  presented  approach.  With  the  help  of
medical  professionals  at  National  Institute  of  Health  (NIH)
Pakistan,  we  are  going  to  test  the  proposed  CLAN  in  real
surgical  scenario  after  meeting  medical  safety  standards.  It
is  imperative  to  demonstrate  practical  beneﬁts  of  CLAN  to
convince  clinicians.  The  CLAN  technique,  though  potentially
the  eventual  goal  of  anesthetic  drug  infusion  is  still  in  early
stages  of  research.  It  is  anticipated  that  such  a  CLAN  system
based  on  a  non-linear  and  robust  control  will  replace  manual
administration  as  well  as  TCI  system  in  very  near  future.
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